GreyBird Ventures is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach. GreyBird Ventures, LLC is the world’s first venture firm focused exclusively on solving the most critical diagnostic problems to accelerate the trend toward precision medicine. Launched by Tom Miller, Michael Devlin, and Scott Gazelle, and supported by a global network of Operating Advisors, we invest early and work closely with entrepreneurs who share our passion and belief that the precise diagnosis of disease is the necessary starting point for successful treatment. We are guided in all of our activities by a strong ethical filter to seek returns that are as humanitarian as they are financially rewarding.